INDIANAPOLIS: This week, pharmaceutical giant Eli Lilly is launching its first installment of a monthly program designed to reach out to journalists. The NewsMaker Forum will include experts from inside and outside the company talking on an array of health-related topics.
The first such program is scheduled for March 24. The topic is Multi-Drug Resistant Tuberculosis and will feature Eli Lilly's Dr. Gail Cassell, Dr. Paul Farmer of Partners in Health and Harvard Medical School, and Dr. Maria Freire from the Global Alliance for TB Drug Development. Dr. Freire will be calling in from India where she will be participating in activities for World TB Day (March 24).
Eli Lilly said it was launching the NewsMaker Forum because coverage of healthcare-related issues has expanded in recent years and because consumers are turning to the media to educate themselves about health-related matters.
"It's a great opportunity for us to tell a good story to the media," said Edward G. Sagebiel, Eli Lilly corporate communications manager. "We have experts, whether from the physicians' side or the regulatory side or the policy side, who can provide insight into important issues and do it on a monthly basis."
Sagebiel said that the topics concern diseases, public policy, government relations, trends, business, and other issues. "Instead of sitting back and waiting for the media to contact us, we'll contact them," he added.
Eli Lilly will announce each month's topic via PR Newswire, along with the date and time, and a call-in number. The discussions are expected to last from 30 to 40 minutes, with a media question-and-answer period following. The company said that in some instances, NewsMaker Forum programs will be accompanied by a VNR, ANR, and/or streaming video.